
Clavspark 125mg/25mg Injection
Marketer
Spark Bless Pharma
Salt Composition
Amoxycillin (125mg) + Clavulanic Acid (25mg)
Overview Clavspark 125mg/25mg Injection
Augmentin 125mg/25mg Injection combats bacterial infections by leveraging its penicillin-based antibiotic properties. This medication effectively treats infections in the lungs (like pneumonia), ears, sinuses, urinary tract, skin, and soft tissues. However, it's ineffective against viral illnesses such as the common cold. Administration of Augmentin 125mg/25mg Injection is exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician, based on your condition's severity, and adherence to the prescribed regimen is crucial. Typical side effects include nausea, vomiting, diarrhea, and oral thrush. Injection site reactions, such as pain, swelling, or redness, may also occur. Persistent or worsening side effects warrant immediate medical attention. Individuals with severe liver or kidney impairment should consult their doctor prior to treatment initiation. Always inform your doctor of any antibiotic allergies or pre-existing kidney or liver conditions before commencing treatment; dosage adjustments or alternative medications may be necessary. Under medical supervision, this medication is generally considered safe for use during pregnancy and breastfeeding.
Uses of Clavspark 125mg/25mg Injection
Preventing bacterial infections related to surgical procedures
Major Benefits of Clavspark 125mg/25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Clavspark 125mg/25mg Injection:
- Vomiting
- Nausea
- Diarrhea
- Thrush
How to use Clavspark 125mg/25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Clavspark 125mg/25mg Injection works:
Clavspark Injection, containing 125mg Amoxycillin and 25mg Clavulanic Acid, combines an antibiotic with a resistance-blocking agent. Amoxycillin's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth and survival. Clavulanic Acid, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby improving Amoxycillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Clavspark 125mg/25mg Injection with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Clavspark, 125mg/25mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harmful effects on fetal development; however, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Clavspark, at a dosage of 125mg/25mg, poses no known breastfeeding risks. Research in human subjects indicates negligible transfer of the drug into breast milk, thereby minimizing potential harm to the infant.
DrivingUNSAFE
Administering Clavspark 125mg/25mg Injection might result in adverse reactions impacting driving capabilities. These reactions can include allergic responses, vertigo, or seizures, rendering operation of a vehicle unsafe.
KidneyCAUTION
Patients with kidney impairment should use Clavspark 125mg/25mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised. This medication is contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Patients with hepatic impairment should use Clavspark 125mg/25mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Routine monitoring of liver function is recommended during treatment.
What if you forget to take Clavspark 125mg/25mg Injection :
Should you forget a Clavspark 125mg/25mg Injection, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing schedule. Never take a double dose.
Facts to Know About Clavspark 125mg/25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
